Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
Public ClinicalTrials.gov record NCT00541320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Dose Ranging Trial for the Evaluation of the Safety and Efficacy of GW813893 in the Prophylaxis of Venous Thromboembolism Post Total Knee Replacement Surgery.
Study identification
- NCT ID
- NCT00541320
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- GW813893 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2007
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Apr 3, 2013
Started 2007
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Clinical Trials Call Center | Birmingham | Alabama | 35209 | — |
| GSK Clinical Trials Call Center' | Phoenix | Arizona | 85023 | — |
| GSK Clinical Trials Call Center | Phoenix | Arizona | 85023 | — |
| GSK Clinical Trials Call Center | Yuba City | California | 95991 | — |
| GSK Clinical Trials Call Center | St. Petersburg | Florida | 33703 | — |
| GSK Clinical Trials Call Center | Decatur | Georgia | 30032 | — |
| GSK Clinical Trials Call Center | Charleston | South Carolina | 29414 | — |
| GSK Clinical Trials Call Center | San Antonio | Texas | 78217 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00541320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 3, 2013 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00541320 live on ClinicalTrials.gov.